MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-19-2025
Vivos Therapeutics Operating Expenses 2011-2026 | VVOS
Annual Operating Expenses Vivos Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.2 M | 25.6 M | 35 M | 33 M | 19.1 M | 19.2 M | 11 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35 M | 11 M | 23.3 M |
Quarterly Operating Expenses Vivos Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.67 M | 6.98 M | 5.43 M | - | 4.98 M | 4.59 M | 5.72 M | - | 5.39 M | 6.62 M | 7.34 M | - | 7.9 M | 9.55 M | 9.19 M | - | 8.69 M | 7.68 M | 6.1 M | - | 4.4 M | 4.14 M | 4.97 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 9.55 M | 4.14 M | 6.57 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Viemed Healthcare
VMD
|
55.7 M | $ 9.21 | -0.11 % | $ 358 M |  USA |
 |
Varex Imaging Corporation
VREX
|
318 M | $ 10.82 | 0.37 % | $ 448 M | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 105.12 | 0.53 % | $ 183 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 165.94 | -6.42 % | $ 12.4 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Beyond Air
XAIR
|
42.9 M | $ 0.68 | -1.74 % | $ 46 M | USA |
 |
Accuray Incorporated
ARAY
|
139 M | $ 0.39 | 4.43 % | $ 40.1 M | USA |
 |
Alphatec Holdings
ATEC
|
614 M | $ 11.05 | -4.12 % | $ 1.66 B | USA |
 |
Xtant Medical Holdings
XTNT
|
80.3 M | $ 0.57 | 0.5 % | $ 76.2 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
4.46 B | $ 88.45 | -0.79 % | $ 18 B | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 34.22 | -3.17 % | $ 5.1 K | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 69.21 | -1.37 % | $ 102 B | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 35.63 | -2.76 % | $ 1.11 B | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
5.09 M | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.59 | -1.68 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
9.34 M | $ 2.22 | -2.2 % | $ 3.47 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 79.12 | -3.63 % | $ 46.3 B | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 11.15 | -2.28 % | $ 1.51 B | USA |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 0.97 | -28.14 % | $ 15.6 M | USA |
 |
Penumbra
PEN
|
753 M | $ 335.13 | -0.38 % | $ 13 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.76 | -3.64 % | $ 370 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 61.5 | -3.38 % | $ 3.35 B |  Britain |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
26.8 M | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.68 | 0.43 % | $ 28.5 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 49.39 | -2.1 % | $ 1.45 B | USA |
 |
Pulmonx Corporation
LUNG
|
121 M | $ 1.17 | -5.65 % | $ 47.6 M | USA |